BLFS forecasts 2026 revenue between $112.5M and $115M after Q1 growth of 25% and adjusted EBITDA up 15%.
BioLife Solutions (BLFS) outlined a 2026 revenue target of $112.5M to $115M while aiming for full-year GAAP net income. The company reported a strong start to the year, with Q1 2026 revenue growth of 25% and adjusted EBITDA rising approximately 15% year-over-year.
The guidance follows a period of expansion, though specific prior-year figures or consensus estimates were not disclosed. Management attributed the growth to solid operational performance and market demand.
No immediate market reaction details were provided in the source.